High materiality7/10
Apogee Therapeutics price target raised to $135 from $81 at Truist
Why it may matterVerify against the original reporting
up target
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Apogee Therapeutics price target raised to $135 from $81 at Truist
- Truist raises APGE target to $135.
Key facts
- 01
Target: $135
- 02
Posted price: $134.54
- 03
Analyst firm: Truist Financial
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.